Identity
- Trade Name
- Eversense NOW Mobile App Android FDA UDI
- Generic Name
- Implantable glucose monitoring system FDA UDI
- Device Name
- The Eversense NOW Remote Monitoring App is intended for home use. The mobile app is intended to be a secondary device used to remotely view an Eversense CGM System user’s glucose information. The secondary display is not a replacement for either real time continuous glucose monitoring using the Eversense CGM System’s primary display, or for home blood glucose monitoring. The Eversense NOW Remote Monitoring App is not intended to be used to make treatment decisions or therapy adjustments. FDA UDI
- Model / Reference
- FG-5902-01-300 FDA UDI
- Description
- The Eversense NOW Remote Monitoring App is intended for home use. The mobile app is intended to be a secondary device used to remotely view an Eversense CGM System user’s glucose information. The secondary display is not a replacement for either real time continuous glucose monitoring using the Eversense CGM System’s primary display, or for home blood glucose monitoring. The Eversense NOW Remote Monitoring App is not intended to be used to make treatment decisions or therapy adjustments. FDA UDI
Identifiers
- Catalog Number
- FG-5902-01-300 FDA UDI
- Primary DI / UDI-DI
- 00817491023490 FDA UDI
- FDA Product Code
- PJT FDA UDI
- GMDN Term
- Implantable glucose monitoring system FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.1350 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Implantable glucose monitoring system
Eversense NOW Mobile App Android by Senseonics, Incorporated — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Implantable glucose monitoring system.
- Eversense Adhesive Patches, 10-pack White — SENSEONICS, INCORPORATED · Class III
- Eversense 365 Mobile Application (iOS) — SENSEONICS, INCORPORATED · Class II
- Eversense® Charging Accessories Pack — SENSEONICS, INCORPORATED · Class III
- Eversense® Adhesive Patches, 30-Pack Clear — SENSEONICS, INCORPORATED · Class III
- Eversense Mobile App iOS — SENSEONICS, INCORPORATED · Class III
- Eversense Mobile App Android — SENSEONICS, INCORPORATED · Class III
- Eversense DMS — SENSEONICS, INCORPORATED · Class I
- Eversense E3 Adhesive Patches Kit, 180-pack — SENSEONICS, INCORPORATED · Class III
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Senseonics, Incorporated
Sources (1)
- FDA UDI c6ac9a0f-ac63-4bc0-a6aa-c80b01d813f1 35 fields · synced May 30, 2026